Diego Castillo

1.9k citations
84 papers · 2.2k · 1 hit paper · h-index 21

Impact in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Cystic Fibrosis Research Advances
    • Lung Cancer Diagnosis and Treatment
  • Physiology top 5%
    • Histiocytic Disorders and Treatments
    • Sarcoidosis and Beryllium Toxicity Research

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 46
    • Chronic Obstructive Pulmonary Disease (COPD) Research 11
    • Sarcoidosis and Beryllium Toxicity Research 6
    • Histiocytic Disorders and Treatments 3

Diego Castillo

78 papers receiving 2.1k citations

Diego Castillo's Hit Papers

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial 2020 · 416 citations
4160+2+4Years since publication100200300400

Peers

Diego Castillo
Comparison fields: 5 of 86
  • Pulmonary and Respiratory Medicine 1.3k
  • Physiology 405
  • Infectious Diseases 153
  • Pharmacology 41
  • Pathology and Forensic Medicine 51
Replace Rafał Krenke with:
Rafał Krenke Poland
José M. Cifrián Spain
Piero Emilio Balbo Italy
Marjorie Patricia George United States
Sabine Adler Switzerland
Yet Hong Khor Australia
Ludovic Le Taillandier de Gabory France
Motoo Araki Japan
K. Randall Young United States
Debdatta Basu India
Diego Castillo relative to Rafał Krenke Poland Rafał Krenke's profile →
Citations per field
00.5×2×4×5.9×
Rafał Krenke · 1×
Citations per year

Countries citing papers authored by Diego Castillo

Since Specialization
Citations

This map shows the geographic impact of Diego Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Castillo more than expected).

Fields of papers citing papers by Diego Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Castillo. The network helps show where Diego Castillo may publish in the future.

Co-authors

The 25 scholars most cited alongside Diego Castillo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diego Castillo Line = papers co-authored together Diego Castillo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Hit paper breakdown →
2020416
2 2014247
3 2013238
4 2020168
5 201989
6 201773
7 200962
8 201459
9 202148
10 201247
11 201547
12 202044
13 201640
14 202340
15 201738
16 201735
17 201533
18 202229
19 201826
20 201622

About Diego Castillo

Diego Castillo is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Pharmacology and Biomedical Engineering, having authored 84 papers that have together received 2.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (46 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Advanced Chemical Sensor Technologies (6 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers), COVID-19 Clinical Research Studies (5 papers), Histiocytic Disorders and Treatments (3 papers), Palliative Care and End-of-Life Issues (3 papers) and Pharmacy and Medical Practices (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Physiology (405 citations), Infectious Diseases (153 citations), Pharmacology (41 citations) and Pathology and Forensic Medicine (51 citations). Diego Castillo has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Alfons Torregó, Vicente Plaza, Jordi Giner, Oriol Sibila, Tomás Franquet, Virginia Pajares, Jürgen Hetzel, David Ramos‐Barbón, Carmen Puzo and Pere Casán. Their work appears in journals such as The Lancet Respiratory Medicine, Respiratory Medicine, Respirology, Archivos de Bronconeumología and BMC Pulmonary Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact